Literature DB >> 9480925

Potentiation of receptor-mediated cAMP production: role in the cross-talk between vasopressin V1a and V2 receptor transduction pathways.

C Klingler1, N Ancellin, M B Barrault, A Morel, B Corman.   

Abstract

Cross-talk between the phospholipase C and adenylyl cyclase signalling pathways was investigated in Chinese hamster ovary (CHO) cells transfected with the V1a and V2 vasopressin receptors. Cell lines expressing V1a, V2, or both V1a and V2 receptors, were established and characterized. Stimulation of V2 receptors by vasopressin induced a dose-dependent increase in cAMP accumulation, whereas stimulation of V1a receptor resulted in an increase in intracellular calcium without any change in basal cAMP. The simultaneous stimulation of V2 and V1a receptors by vasopressin elicited an intracellular cAMP accumulation which was twice that induced by stimulation of V2 receptor alone with deamino-[d-Arg8]vasopressin. This potentiation between V1a and V2 receptors was mimicked by activation of protein kinase C (PKC) with PMA, and was suppressed when PKC activity was inhibited by bisindolylmaleimide. The potentiation was observed in the presence or absence of 1 mM 3-isobutyl-1-methylxanthine, a phosphodiesterase inhibitor, implying that an alteration in cAMP hydrolysis was not involved. Vasopressin, as well as PMA, had no effect on the forskolin-induced cAMP accumulation, suggesting that PKC did not directly stimulate the cyclase activity. On the other hand, vasopressin, like PMA, potentiated the cAMP accumulation induced by cholera toxin, an activator of Galphas protein. These results suggest that, in CHO cells, vasopressin V1a receptor potentiates the cAMP accumulation induced by the V2 receptor through a PKC-dependent increase in the coupling between Gs protein and adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9480925      PMCID: PMC1219240          DOI: 10.1042/bj3301023

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.

Authors:  H Yu; J J Cai; H C Lee
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

2.  Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase.

Authors:  T Katada; A G Gilman; Y Watanabe; S Bauer; K H Jakobs
Journal:  Eur J Biochem       Date:  1985-09-02

Review 3.  Regulation of cellular calcium through signaling cross-talk involves an intricate interplay between the actions of receptors, G-proteins, and second messengers.

Authors:  F L Bygrave; H R Roberts
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

4.  Regulation of type V adenylyl cyclase by PMA-sensitive and -insensitive protein kinase C isoenzymes in intact cells.

Authors:  J i Kawabe; T Ebina; Y Toya; N Oka; C Schwencke; E Duzic; Y Ishikawa
Journal:  FEBS Lett       Date:  1996-04-22       Impact factor: 4.124

5.  Molecular biology of vasopressin receptors.

Authors:  S J Lolait; A M O'Carroll; M J Brownstein
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

6.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

7.  Activation of cyclic AMP-generating systems in brain membranes and slices by the diterpene forskolin: augmentation of receptor-mediated responses.

Authors:  J W Daly; W Padgett; K B Seamon
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

Review 8.  Forskolin, adenylate cyclase, and cell physiology: an overview.

Authors:  J W Daly
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

9.  Multi-site phosphorylation of the inhibitory guanine nucleotide regulatory protein Gi-2 occurs in intact rat hepatocytes.

Authors:  N J Morris; M Bushfield; B E Lavan; M D Houslay
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

10.  Implication of protein kinase C alpha in PAF-stimulated phospholipase D activation in Chinese hamster ovary (CHO) cells expressing PAF receptor.

Authors:  B Liu; S Nakashima; T Takano; T Shimizu; Y Nozawa
Journal:  Biochem Biophys Res Commun       Date:  1995-09-14       Impact factor: 3.575

View more
  3 in total

1.  Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase.

Authors:  A D Qi; C Kennedy; T K Harden; R A Nicholas
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling.

Authors:  Elena A Zalyapin; Richard Bouley; Udo Hasler; Jean-Pierre Vilardaga; Herbert Y Lin; Dennis Brown; Dennis A Ausiello
Journal:  Kidney Int       Date:  2008-08-27       Impact factor: 10.612

3.  β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.

Authors:  Douglas G Tilley; Weizhong Zhu; Valerie D Myers; Larry A Barr; Erhe Gao; Xue Li; Jianliang Song; Rhonda L Carter; Catherine A Makarewich; Daohai Yu; Constantine D Troupes; Laurel A Grisanti; Ryan C Coleman; Walter J Koch; Steven R Houser; Joseph Y Cheung; Arthur M Feldman
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.